Adhesions as a risk factor for postoperative morbidity in patients undergoing repeat hepatectomy and the potential efficacy of adhesion barriers.

adhesion adhesion barrier colorectal liver metastasis hepatocellular carcinoma repeat hepatectomy

Journal

Journal of hepato-biliary-pancreatic sciences
ISSN: 1868-6982
Titre abrégé: J Hepatobiliary Pancreat Sci
Pays: Japan
ID NLM: 101528587

Informations de publication

Date de publication:
Jun 2022
Historique:
revised: 27 08 2021
received: 29 06 2021
accepted: 03 09 2021
pubmed: 21 9 2021
medline: 1 7 2022
entrez: 20 9 2021
Statut: ppublish

Résumé

The actual efficacy of use of adhesion barriers during liver surgery remains to be fully understood. We conducted an extensive review of clinical data and operation videos of 210 patients who underwent repeat hepatectomy to clarify the factors associated with the degree of adhesion as evaluated by the TORAD score. Adhesion barriers were placed in 131 patients (Seprafilm A high degree of adhesion formation was directly associated with an increased risk of postoperative morbidity after relaparotomy, and use of adhesion barriers appears to reduce the extent of adhesion.

Sections du résumé

BACKGROUND BACKGROUND
The actual efficacy of use of adhesion barriers during liver surgery remains to be fully understood.
METHODS METHODS
We conducted an extensive review of clinical data and operation videos of 210 patients who underwent repeat hepatectomy to clarify the factors associated with the degree of adhesion as evaluated by the TORAD score.
RESULTS RESULTS
Adhesion barriers were placed in 131 patients (Seprafilm
CONCLUSION CONCLUSIONS
A high degree of adhesion formation was directly associated with an increased risk of postoperative morbidity after relaparotomy, and use of adhesion barriers appears to reduce the extent of adhesion.

Identifiants

pubmed: 34541819
doi: 10.1002/jhbp.1047
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

618-628

Subventions

Organisme : Okinaka Memorial Institute for Medical Research
Organisme : Okinaka Memorial Institute for Medical Disease

Informations de copyright

© 2021 Japanese Society of Hepato-Biliary-Pancreatic Surgery.

Références

Oba M, Hasegawa K, Matsuyama Y, Shindoh J, Mise Y, Aoki T, et al. Discrepancy between recurrence-free survival and overall survival in patients with resectable colorectal liver metastases: a potential surrogate endpoint for time to surgical failure. Ann Surg Oncol. 2014;21(6):1817-24.
Shindoh J, Kawamura Y, Kobayashi Y, Akuta N, Kobayashi M, Suzuki Y, et al. Time-to-interventional failure as a new surrogate measure for survival outcomes after resection of hepatocellular carcinoma. J Gastrointest Surg. 2020;24(1):50-7.
Mise Y, Hasegawa K, Shindoh J, Ishizawa T, Aoki T, Sakamoto Y, et al. The feasibility of third or more repeat hepatectomy for recurrent hepatocellular carcinoma. Ann Surg. 2015;262(2):347-57.
Kobayashi Y, Shindoh J, Igata Y, Okubo S, Hashimoto M. A novel scoring system for evaluating the difficulty of lysis of adhesion and surgical risk at repeat hepatectomy. J Hepatobiliary Pancreat Sci. 2020;27(4):191-9.
Okubo S, Shindoh J, Kobayashi Y, Hashimoto M. Safety of bioabsorbable membrane (Seprafilim(R)) in hepatectomy in the era of aggressive liver surgery. HPB. 2021;23(4):528-32.
Okubo S, Shindoh J, Kobayashi Y, Hashimoto M. Safety of a new spray-type adhesion barrier (AdSpray((R)) ) in liver surgery. J Hepatobiliary Pancreat Sci. 2020;27(9):648-54.
Okubo S, Shindoh J, Kobayashi Y, Hashimoto M. Safety of use of a sheet-type adhesion barrier (Interceed((R))) during liver surgery. World J Surg. 2020;44(12):4214-20.
Kobayashi Y, Shindoh J, Okubo S, Tani K, Morito M, Igata Y, et al. Hyaluronic acid/ carboxymethyl cellulose-based adhesion barrier reduces surgical difficulty and complication in repeat hepatectomy. HPB. 2021;23(6):907-14.
Kobayashi Y, Shindoh J, Okubo S, Tani K, Morito M, Igata Y, et al. Hyaluronic acid/ carboxymethyl cellulose-based adhesion barrier reduces surgical difficulty and complication in repeat hepatectomy. HPB. 2021;23(6):907-14.
Kobayashi Y, Kiya Y, Sugawara T, Nishioka Y, Hashimoto M, Shindoh J. Expanded Makuuchi's criteria using estimated indocyanine green clearance rate of future liver remnant as a safety limit for maximum extent of liver resection. HPB. 2019;21(8):990-7.
Kobayashi Y, Kiya Y, Nishioka Y, Hashimoto M, Shindoh J. Indocyanine green clearance of remnant liver (ICG-Krem) predicts postoperative subclinical hepatic insufficiency after resection of colorectal liver metastasis: theoretical validation for safe expansion of Makuuchi's criteria. HPB. 2020;22(2):258-64.
Naito M, Ogura N, Yamanashi T, Sato T, Nakamura T, Miura H, et al. Prospective randomized controlled study on the validity and safety of an absorbable adhesion barrier (Interceed(R)) made of oxidized regenerated cellulose for laparoscopic colorectal surgery. Asian J Endosc Surg. 2017;10(1):7-11.
Watanabe J, Ishida F, Ishida H, Fukunaga Y, Watanabe K, Naito M, et al. A prospective multi-center registry concerning the clinical performance of laparoscopic colorectal surgery using an absorbable adhesion barrier (INTERCEED((R))) made of oxidized regenerated cellulose. Surg Today. 2019;49(10):877-84.
Diamond MP. Reduction of adhesions after uterine myomectomy by Seprafilm membrane (HAL-F): a blinded, prospective, randomized, multicenter clinical study. Seprafilm Adhesion Study Group. Fertil Steril. 1996;66(6):904-10.
Mohri Y, Uchida K, Araki T, Inoue Y, Tonouchi H, Miki C, et al. Hyaluronic acid-carboxycellulose membrane (Seprafilm) reduces early postoperative small bowel obstruction in gastrointestinal surgery. Am Surg. 2005;71(10):861-3.
Saito G, Sadahiro S, Ogimi T, Miyakita H, Okada K, Tanaka A, et al. Preventive effects of a synthetic absorbable antiadhesive film (seprafilm) on small bowel obstruction in patients who underwent elective surgery for colon cancer: a randomized controlled trial. J Surg Oncol. 2019;120(6):1038-43.
Tabata T, Kihira T, Shiozaki T, Tanida K, Kondo E, Nagao K, et al. Efficacy of a sodium hyaluronate-carboxycellulose membrane (seprafilm) for reducing the risk of early postoperative small bowel obstruction in patients with gynecologic malignancies. Int J Gynecol Cancer. 2010;20(1):188-93.
Beck DE, Cohen Z, Fleshman JW, Kaufman HS, van Goor H, Wolff BG. A prospective, randomized, multicenter, controlled study of the safety of Seprafilm adhesion barrier in abdominopelvic surgery of the intestine. Dis Colon Rectum. 2003;46(10):1310-9.
Dupré A, Lefranc A, Buc E, Delpero JR, Quenet F, Passot G, et al. Use of bioresorbable membranes to reduce abdominal and perihepatic adhesions in 2-stage hepatectomy of liver metastases from colorectal cancer: results of a prospective, randomized controlled phase II trial. Ann Surg. 2013;258(1):30-6.
Shimizu A, Hasegawa K, Masuda K, Omichi K, Miyata A, Kokudo N. Efficacy of hyaluronic acid/carboxymethyl cellulose-based bioresorbable membranes in reducing perihepatic adhesion formation: a prospective cohort study. Dig Surg. 2018;35(2):95-103.

Auteurs

Satoshi Okubo (S)

Hepato-Biliary-Pancreatic Surgery Division, Department of Gastroenterological Surgery, Toranomon Hospital, Tokyo, Japan.
Okinaka Memorial Institute for Medical Disease, Tokyo, Japan.

Junichi Shindoh (J)

Hepato-Biliary-Pancreatic Surgery Division, Department of Gastroenterological Surgery, Toranomon Hospital, Tokyo, Japan.
Okinaka Memorial Institute for Medical Disease, Tokyo, Japan.

Yuta Kobayashi (Y)

Hepato-Biliary-Pancreatic Surgery Division, Department of Gastroenterological Surgery, Toranomon Hospital, Tokyo, Japan.

Masaru Matsumura (M)

Hepato-Biliary-Pancreatic Surgery Division, Department of Gastroenterological Surgery, Toranomon Hospital, Tokyo, Japan.
Department of Surgery, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan.

Masaji Hashimoto (M)

Hepato-Biliary-Pancreatic Surgery Division, Department of Gastroenterological Surgery, Toranomon Hospital, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH